The American Association of Pharmaceutical Scientists (AAPS) has announced that its 2026 PharmSci 360 meeting will take place October 25 to 28 at the Ernest N. Morial Convention Center in New Orleans. The event is the organization's premier annual gathering, expected to draw thousands of scientists from academia, industry, and government.
AAPS, which counts roughly 7,000 members, uses the conference as a platform for sharing the latest advances in pharmaceutical science. The meeting typically features presentations, workshops, and networking sessions focused on drug discovery, development, and manufacturing.
New Orleans was selected as the host city for 2026, continuing the event's rotation among major U.S. convention destinations. The Ernest N. Morial Convention Center offers extensive exhibition and meeting space to accommodate the large scientific audience.
While the conference does not directly involve clinical trials or drug approvals, it plays a key role in fostering collaboration and disseminating research findings. The event's timing in late October avoids overlap with other major industry conferences.
Some researchers may question whether the meeting provides enough value relative to other specialized pharmaceutical conferences. The broad scope of PharmSci 360 means deep dives into specific therapeutic areas may be limited compared to niche symposia.